Bio-Path Holdings, Inc.
Bio-Path Holdings, Inc. (BPTH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BPTH · as of Jun 9, 2026
Key Statistics
Explore Bio-Path Holdings, Inc. Data
bpth stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 100.0%
Competitors & Peers
bpth competitorsBPTH
ELLXF
EMMA
HXBM
IDCN
ORGSStock Performance
Full HistoryAbout Bio-Path Holdings, Inc.
Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on developing RNAi nanoparticle drugs for oncology, with programs spanning both clinical and preclinical stages. Its innovative p…
what is bio-path holdings, inc. · bpth stock overview · bio-path holdings, inc. company profile · who is bio-path holdings, inc. ceo · bpth OTC · bio-path holdings, inc. headquarters · bio-path holdings, inc. business segments
About Stock Overview & Key Data
Bio-Path Holdings, Inc. (BPTH) is a Healthcare company in the Biotechnology industry, listed on OTC since Mar 4, 2008. As of the latest trading session, BPTH stock price is $0.03, with a market capitalization of $298,949. The stock has returned -83.16% over the past 12 months and -46.67% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Bio-Path Holdings, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Bio-Path Holdings, Inc. reported revenue of — and net income of -$8.7M. For detailed data — including Bio-Path Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bio-Path Holdings, Inc. (BPTH) stock price is $0.03. The stock is traded on OTC under the ticker symbol BPTH. The 52-week range is $0.01 – $0.23.